Cardinal Health, Inc. company logo

# 1st Gen Model Cardinal Health, Inc. Drugs, proprietaries, & sundries

64.71% successful of 51 deals
$63.19 Last close price
at 15-dec-2017


Model's trade recommendations 0.03% Return for period

-13.14% Annual return

$19.06B Market Cap

β 0.85  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period 0.03%
52wk return -13.94%
52wk Range
Sortino ratio -1.04
Sharpe ratio -1.01
Norm. RMSE 0.65%
Downside risk 12.92%
Volatility 13.37%
  • 1.85 (3.05%) Div (Yield)
  • HOLD Analysts consensus recommendation

Cardinal Health, Inc. is a global, integrated healthcare services and products company, providing customized solutions for hospitals, health systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. The company provides clinically-proven medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency from hospital to home. Cardinal Health connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management. Cardinal Health is more than a business, more than a partner, more than hard workers. Its unrivaled scale and focused approach leads to better solutions. The company's strength flows from four areas of expertise: logistics, product, business and patient solutions. Cardinal Health welcomes new challenges, anticipates trends, and as Wings, brings support, speed, and mile-high vision to all customers.

Industry sector: Medical

Sector classification: Drugs, proprietaries, & sundries

Deep Learning based analysis and prediction model for Cardinal Health, Inc. (CAH) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 2, 2015.

Market data for CAH model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 312M
P/E 11.49
Shares Outstanding 315M
% Held by Insiders 0.97%
% Held by Institutions 88.47%
EPS (last reported FY) $5.40
EPS (last reported Q) $1.09
EPS, estimated (last reported Q) $1.01
Total revenues $130 B
Net income $1 B